Medpace Holdings, Inc.
MEDPFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
2,109
Cost of Revenue
1,453
Gross Profit
656
Gross Margin
31.1%
Operating Income
447
Operating Margin
21.2%
Net Income
404
Net Margin
19.2%
EPS (Basic)
$13.06
EPS (Diluted)
$12.63
EBITDA
476
EBITDA Margin
22.6%
2023
12/31/2023
Revenue
1,886
Cost of Revenue
1,361
Gross Profit
525
Gross Margin
27.8%
Operating Income
337
Operating Margin
17.9%
Net Income
283
Net Margin
15.0%
EPS (Basic)
$9.20
EPS (Diluted)
$8.88
EBITDA
363
EBITDA Margin
19.3%
2022
12/31/2022
Revenue
1,460
Cost of Revenue
1,028
Gross Profit
432
Gross Margin
29.6%
Operating Income
279
Operating Margin
19.1%
Net Income
245
Net Margin
16.8%
EPS (Basic)
$7.57
EPS (Diluted)
$7.28
EBITDA
301
EBITDA Margin
20.6%
2021
12/31/2021
Revenue
1,142
Cost of Revenue
814
Gross Profit
328
Gross Margin
28.7%
Operating Income
199
Operating Margin
17.4%
Net Income
182
Net Margin
15.9%
EPS (Basic)
$5.06
EPS (Diluted)
$4.81
EBITDA
220
EBITDA Margin
19.2%
2020
12/31/2020
Revenue
926
Cost of Revenue
647
Gross Profit
279
Gross Margin
30.1%
Operating Income
167
Operating Margin
18.0%
Net Income
145
Net Margin
15.7%
EPS (Basic)
$4.07
EPS (Diluted)
$3.84
EBITDA
187
EBITDA Margin
20.1%